Pharmaceutical companies are able to minimize drug waste and increase product life span, while patients are able to self administer inject-able drugs at their home instead of the hospital with the help of prefilled syringes. Prefilled syringe helps in lower overfill, provides greater efficiency, reduces risk of dosage error and contamination, provide ease of use and convenient for both medical professionals and patients.
In 2014, the global prefilled syringes market size was valued over USD 3.0 billion; while in 2015, the global prefilled syringes market surpassed USD x.x billion which is projected to grow with a CAGR between 9.0% and 9.5% during the forecast period 2016-2022 and reach to USD xx.x billion by 2022. Increasing chronic diseases which require frequent drug dosage, technological advancements, convenience and benefits associated with prefilled syringes, increase patient compliance, and increase home-based healthcare trend among the people are the key factors driving the growth of prefilled syringes market.
The major restraints for prefilled syringes market are storage problem for this syringes as they require refrigerator storage, cost associated with the manufacturing process and strict government regulations. As prefilled syringes are becoming most common for home-based inject-able drug administration for the treatment of chronic disease, is considered to be a key opportunity for players in the market. The primary challenges face by this market involves manufacturing of prefilled syringes and stringent government regulations.
The report segments the Prefilled syringes market by, product type, by therapeutic category and by design. The market segmentation based on product type includes glass pre filled syringes and plastic pre filled syringes. Furthermore, glass pre filled syringes segment dominated the market in past due to its material properties such as robustness, transparency and its non-reactive nature. However, plastic prefilled syringes are expected to grow at a faster CAGR during forecast period due to development of polymer used to manufacture plastic prefilled syringes.
The global prefilled syringes market based on therapeutic category is segmented into insulin prefilled syringes, vaccine prefilled syringes, arthritis prefilled syringes, heparin prefilled syringes, and PCSK9 inhibiter prefilled syringes and other prefilled syringes. Moreover, based on design the global prefilled syringes market is segmented into single chamber prefilled syringes, dual chamber prefilled syringes and customized prefilled syringes.
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). Europe is accounted as the largest market share in prefilled syringes market due to high rate of adoption of prefilled syringes and presence of large number of key players in this region are the factors driving the dominance of this region. Moreover, growing adoption rate and technological advancements make North America the fastest growing region in this market. Asia pacific is expected to be the second fastest growing region in prefilled syringes market over the forecast period due to untapped market, increase in purchasing power of the patients, increasing awareness about prefilled syringes among the people.
The companies covered in the report include Becton, Dickinson and Company, Baxter International Inc., Niulife Corporation, Consort Medical plc, Ypsomed Holding AG, Nipro Corporation, West Pharmaceutical Services, Inc, SCHOTT AG, SHL Group, Haselmeier AG, Weigao Group, AptarGroup, Inc., and Medtronic plc
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of prefilled syringes globally as well as regionally. Moreover, the Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of prefilled syringes market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2022. We also have highlighted future trends in the prefilled syringes market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players.
Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors of the prefilled syringes market to understand the present and future trends in this market and formulate their strategies accordingly.
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Pre Filled Syringes Market Overview
3.2 Market Dynamics
3.7 Porter’s Five Forces Analysis
3.8 Growth Matrix Analysis
3.9 Competitive Landscape in the Pre Filled Syringes Market
4. Global Pre Filled Syringes Market, by Product Type, (USD Million) 2014-2022
4.2 Glass Pre Filled Syringes
4.3 Plastic Pre Filled Syringes
5. Global Pre Filled Syringes Market, by Therapeutic Category, (USD Million) 2014-2022
5.2 Insulin Pre Filled Syringes
5.3 Vaccine Pre Filled Syringes
5.4 Arthritis Pre Filled Syringes
5.5 Heparin Pre Filled Syringes
5.6 PCSK9 Inhibitor Pre Filled Syringes
5.7 Others Pre Filled Syringes
6. Global Pre Filled Syringes Market, by Design, (USD Million) 2014-2022
6.2 Single-Chamber Prefilled Syringes
6.3 Dual-Chamber Prefilled Syringes
6.4 Customized Prefilled Syringes
7. Global Pre Filled Syringes Market, by Region, (USD Million) 2014-2022
7.2 North America
7.2.1 North America Pre Filled Syringes Market, by Product Type (USD Million)
7.2.2 North America Pre Filled Syringes Market, by Therapeutic Category (USD Million)
7.2.3 North America Pre Filled Syringes Market, by Design (USD Million)
7.3.1 Europe Pre Filled Syringes Market, by Product Type (USD Million)
7.3.2 Europe Pre Filled Syringes Market, by Therapeutic Category (USD Million)
7.3.3 Europe Pre Filled Syringes Market, by Design (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Pre Filled Syringes Market, by Product Type (USD Million)
7.4.2 Asia Pacific Pre Filled Syringes Market, by Therapeutic Category (USD Million)
7.4.3 Asia Pacific Pre Filled Syringes Market, by Design (USD Million)
7.5 Latin America
7.5.1 Latin America Pre Filled Syringes Market, by Product Type (USD Million)
7.5.2 Latin America Pre Filled Syringes Market, by Therapeutic Category (USD Million)
7.5.3 Latin America Pre Filled Syringes Market, by Design (USD Million)
7.6 Rest of the World
7.6.1 RoW Pre Filled Syringes Market, by Product Type (USD Million)
7.6.2 RoW Pre Filled Syringes Market, by Therapeutic Category (USD Million)
7.6.3 RoW Pre Filled Syringes Market, by Design (USD Million)
8. Leading Companies
8.1 Company Profiles
8.1.1 Becton, Dickinson and Company
8.1.2 Baxter International Inc.,
8.1.3 Niulife Corporation,
8.1.4 Consort Medical plc
8.1.5 Ypsomed Holding AG
8.1.6 Nipro Corporation
8.1.7 West Pharmaceutical Services, Inc
8.1.8 SCHOTT AG
8.1.9 SHL Group
8.1.10 Haselmeier AG,
8.1.11 Weigao Group
8.1.12 AptarGroup, Inc.
8.1.13 Medtronic plc
- AptarGroup, Inc.
- Baxter International Inc.,
- Becton, Dickinson and Company
- Consort Medical plc
- Haselmeier AG,
- Medtronic plc
- Nipro Corporation
- Niulife Corporation,
- SCHOTT AG
- SHL Group
- Weigao Group
- West Pharmaceutical Services, Inc
- Ypsomed Holding AG